Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Payel Gupta

Allergy & Immunology Brooklyn, NY Medical Doctor

NPI 1457533077 CMS profile 66264

586 President St, Brooklyn, NY 11215

Open in the dashboard

General payments

$256,110

439 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Payel Gupta of Brooklyn, NY is reported in the CMS Open Payments database as having received $256,110 across 439 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Allergy & Immunology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $81,469 91
2024 General $81,537 89
2023 General $60,280 113
2022 General $19,451 48
2021 General $9,522 19
2020 General $1,438 15
2019 General $2,412 64

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Payel Gupta
  • Allergy & Immunology median
  • Middle half of Allergy & Immunology
  • National median

In program year 2025, general payments to Payel Gupta were reported at $81,469. Among 2,466 Allergy & Immunology profiles paid that year, the median was $1,140 and the middle half received between $272 and $2,892.

Show as a table
Year Payel Gupta Allergy & Immunology median Middle half National median
2019 $2,412 $594 $163–$1,512 $163
2020 $1,438 $426 $106–$1,233 $114
2021 $9,522 $638 $157–$1,708 $132
2022 $19,451 $790 $205–$1,961 $149
2023 $60,280 $852 $220–$2,147 $160
2024 $81,537 $865 $203–$2,267 $164
2025 $81,469 $1,140 $272–$2,892 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Genzyme Corporation $61,636 89 payments
  2. Novartis Pharmaceuticals Corporation $58,765 56 payments
  3. GlaxoSmithKline, LLC. $38,383 41 payments
  4. Teva Pharmaceuticals USA, Inc. $19,606 19 payments
  5. Amgen Inc. $16,212 2 payments
  6. ALK-Abello, Inc $14,231 40 payments
  7. Genentech USA, Inc. $10,866 25 payments
  8. Regeneron Healthcare Solutions, Inc. $9,786 28 payments
  9. AstraZeneca Pharmaceuticals LP $9,246 67 payments
  10. Moderna TX, Inc. $5,091 2 payments
  11. Other $12,288 70 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $195,686 38 payments
  2. Food and Beverage $20,001 330 payments
  3. Travel and Lodging $17,011 55 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $15,975 9 payments
  5. Honoraria $7,418 6 payments
  6. Education $19 1 payment
Products named General payments · program years 2019–2025
  1. DUPIXENT Immunology $43,923 74 payments
  2. Xolair $11,055 29 payments
  3. DUPIXENT Inflammation And Immunology $9,825 27 payments
  4. Moderna Covid-19 Vaccine $5,091 2 payments
  5. Odactra $4,343 19 payments
  6. SHINGRIX $3,900 1 payment
  7. VTAMA $2,966 8 payments
  8. Zoryve $1,543 3 payments
  9. ProAir Digihaler $1,194 8 payments
  10. ArmonAir Digihaler $1,194 8 payments
  11. Other $8,168 150 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

439 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Allergy & Immunology in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record